MM

Mayankkumar Maheshbhai Akbari

Active Director Designated Partner DIN 09256561
DIN 09256561 First appointment Jul 2021 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mayankkumar Maheshbhai Akbari

Data last updated:

Mayankkumar Maheshbhai Akbari is a Designated Partner at Aagney Pharmaceuticals Llp (since 2021). The company operates in Business Services.

DIN 09256561
Primary Designation Designated Partner
Industry Business Services
First Appointment 27 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Jul 20212021Active

Board colleagues of Mayankkumar Maheshbhai Akbari

NameDINCompanyDesignation
Dhruv Nileshbhai Patvana09256562Aagney Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Aagney Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Mayankkumar Maheshbhai Akbari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayankkumar Maheshbhai Akbari

Mayankkumar Maheshbhai Akbari currently holds 1 directorship: Aagney Pharmaceuticals Llp (Designated Partner, since 27 Jul 2021).

Mayankkumar Maheshbhai Akbari was first appointed on 27 Jul 2021 as Designated Partner at Aagney Pharmaceuticals Llp.

The current boards of Mayankkumar Maheshbhai Akbari's companies include Dhruv Nileshbhai Patvana (Aagney Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available